中瑞药业 (430645.OC)

+ 收藏

资产负债表(中瑞药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表
流动资产:
 货币资金(元) 49,612,114.9954,921,310.0815,105,243.7840,811,364.08
  其中:交易性金融资产(元) 5,651,638.593,000,000.00-12,000,000.00
 应收票据及应收账款(元) 14,182,318.684,895,570.825,006,085.467,418,769.65
  其中:应收票据(元) 10,217,016.501,216,832.802,028,375.122,028,050.00
  其中:应收账款(元) 3,965,302.183,678,738.022,977,710.345,390,719.65
 预付款项(元) 17,509,756.0515,740,040.1462,102,826.479,230,224.02
 其他应收款(元) 253,002.50861,225.00161,225.00268,000.00
 存货(元) 39,968,581.1433,203,795.6326,476,156.5933,745,627.31
 其他流动资产(元) 2,869,243.6512,950,545.4512,754,359.9710,016,811.46
 流动资产合计(元) 130,046,655.60125,572,487.12121,605,897.27113,490,796.52
非流动资产:
 长期股权投资(元) -19,001,000.00--
 固定资产(元) 138,131,659.22162,736,345.51156,827,491.8275,698,335.38
 在建工程(元) 40,006,249.006,447,976.244,907,977.9378,745,291.24
 使用权资产(元) 1,897,395.402,520,002.842,988,923.663,329,429.61
 无形资产(元) 10,325,140.7711,096,424.6111,867,714.0312,681,366.87
 商誉(元) 1,000.00---
 长期待摊费用(元) 472,613.14278,730.0010,290,233.991,198,109.80
 递延所得税资产(元) 1,407,320.10704,187.40703,686.99401,436.99
 其他非流动资产(元) -2,000,000.002,000,000.0016,892,649.08
 非流动资产合计(元) 192,241,377.63204,784,666.60189,586,028.42188,946,618.97
资产总计(元) 322,288,033.23330,357,153.72311,191,925.69302,437,415.49
流动负债:
 短期借款(元) 35,000,000.0052,980,000.0041,000,000.0028,000,000.00
 应付票据及应付账款(元) 27,915,767.8622,318,137.6322,921,976.587,925,062.17
  其中:应付账款(元) 27,915,767.8622,318,137.6322,921,976.587,925,062.17
 预收款项(元) -5,815,568.793,475,629.50726,675.48
 合同负债(元) 3,676,332.01---
 应付职工薪酬(元) 915,176.53846,142.731,001,030.81925,344.50
 应交税费(元) 685,392.851,427,500.402,073,511.082,734,134.00
 其他应付款(元) 7,659,467.115,032,118.442,873,214.252,718,474.37
 其他流动负债(元) 4,789,516.50---
 流动负债合计(元) 80,641,652.8688,419,467.9973,345,362.2243,029,690.52
非流动负债:
 长期借款(元) 10,800,000.0010,900,000.008,000,000.00-
 租赁负债(元) 2,017,771.822,684,884.032,684,884.033,395,247.53
 专项应付款(元) 200,000.00---
 预计负债(元) 708,500.00708,500.00708,500.00722,650.95
 递延收益(元) 603,873.64672,655.93696,492.31761,404.76
 递延所得税负债(元) 379,479.08---
 非流动负债合计(元) 14,709,624.5414,966,039.9612,089,876.344,879,303.24
负债合计(元) 95,351,277.40103,385,507.9585,435,238.5647,908,993.76
所有者权益(或股东权益):
 实收资本或股本(元) 37,817,967.0037,817,967.0037,817,967.0037,817,967.00
 资本公积(元) 60,559,442.2260,559,442.2260,559,442.2260,559,442.22
 盈余公积(元) 19,321,296.1117,737,215.2817,737,215.2816,576,948.94
 未分配利润(元) 70,866,758.1770,388,866.8966,843,096.7493,350,895.15
 归属于母公司股东权益合计(元) 188,565,463.50186,503,491.39182,957,721.24208,305,253.31
 少数股东权益(元) 38,371,292.3340,468,154.3842,798,965.8946,223,168.42
 股东权益合计(元) 226,936,755.83226,971,645.77225,756,687.13254,528,421.73
负债和股东权益合计(元) 322,288,033.23330,357,153.72311,191,925.69302,437,415.49
公告日期 2024-04-242023-08-162023-04-202022-08-16
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院